[1] Monitoring recommendations for patients using both medications include: Regular blood glucose testing particularly post-lunch and early evening when morning prednisolone is used Consider action if readings are persistently above 12 mmol/L (with individualisation based on your care plan) HbA1c measurement every 3 months for patients with diabetes or prediabetes Fasting glucose checks if not previously diabetic, particularly during corticosteroid therapy Symptom awareness for hyperglycaemia (increased thirst, frequent urination, fatigue, blurred vision) Patients with established diabetes may require adjustments to their glucose-lowering regimen whilst on prednisolone

Other important risks include acute pancreatitis, gallbladder disease (including cholelithiasis and cholecystitis), acute kidney injury (particularly in patients experiencing severe gastrointestinal symptoms), hypoglycemia when used with insulin or insulin secretagogues, increased heart rate, diabetic retinopathy complications in patients with diabetes, and suicidal behavior or ideation
It is essential to use semaglutide as your healthcare provider prescribes to get the best weight loss results
The side effects one person experiences may not occur in another
They may potentially increases the risk of pancreatitis and in some cases the patient may also experience hypoglycemia and allergic reactions
CellPhoneDB: inferring cellcell communication from combined expression of multi-subunit ligand-receptor complexes